Medical Affairs

Transforming Medical Affairs into a Strategic Driver for Success 

Talk with an expert

Unlocking the Full Potential of Medical Affairs

Medical Affairs forms a critical strategic pillar alongside R&D and Commercial, driving differentiated strategy through deep understanding of therapeutic science, clinical applicability, and patient impact.

We partner with you to build and optimize your Medical Affairs function, enabling you to effectively develop, communicate, and augment your product value proposition throughout all stages of the product lifecycle.

Strategic Planning and Alignment

Effective Medical Affairs planning requires a deep understanding of the complex interplay between the healthcare environment, therapeutic landscape, and organizational objectives. Our team collaborates closely with you to develop a comprehensive Medical Affairs strategy that aligns with your overall corporate goals. We conduct a thorough situational analysis, identify key gaps and opportunities, and create a roadmap that prioritizes initiatives and tactics to drive success. 

Through cross-functional collaboration and stakeholder engagement, we ensure that your Medical Affairs strategy is optimized and fully integrated to address the current development stage of your organization.

Stakeholder Engagement and Scientific Communications

Building strong relationships with key opinion leaders (KOLs) through consistent and robust scientific communications are critical components in every successful Medical Affairs strategy. Our team helps you identify, map, and engage with the right KOLs to amplify your message and drive scientific exchange. 

We develop tailored and measurable engagement plans that leverage a variety of tactics to achieve medical and organization objectives. 

Evidence Generation and Dissemination

Generating high-quality evidence is essential to support regulatory and clinical decision-making. Our Medical Affairs experts, in collaboration with our dedicated Evidence & Value team, help you design and execute a robust evidence generation strategy. 

We support you in creating an integrated evidence plan, generating real-world evidence to supplement data requirements for regulators, payers, and clinicians. Our team assists you in effectively communicating your findings through publications and congress activities. By engaging with our Evidence & Value team, you gain access to additional expertise and resources to strengthen your evidence generation and dissemination efforts. 

Comprehensive Support for Your Medical Affairs Needs

We act as an extension of your team, providing the expertise and support you need to revolutionize your Medical Affairs function. Our mission is to help you develop and implement tailored solutions that drive strategic value and improve patient lives. 

Our comprehensive range of services is designed to address your unique needs, from medical operations and infrastructure to scientific and medical communication, stakeholder engagement and insights, evidence generation and dissemination, and patient advocacy and partnerships. 

Why Partner with Us for Your Medical Affairs Needs?

Collaborating with us means more than just engaging a service provider; it means gaining a trusted partner who understands the intricacies of the life sciences industry. Our team combines strategic thinking with extensive practical experience to help you address the unique challenges of optimizing your Medical Affairs function. 

We take a strategy-first approach, working closely with you to align your Medical Affairs initiatives with your overarching business objectives. Our industry expertise allows us to provide tailored solutions that meet your specific needs, from evidence generation and stakeholder engagement to medical education and patient advocacy. 

With a strong commitment to driving results, we help you transform your Medical Affairs department into a strategic asset that creates value for both patients and your business. 

SERVICE LEADERSHIP

Erik Neu

VP Business Consulting

Erik Neu

VP Business Consulting

Erik Neu is a senior consulting leader with 24 years in the Life Sciences industry, including 14 years dedicated to scientific, medical, and clinical functions. As Vice President at SSI Strategy, he excels in aligning complex medical and clinical operations with corporate objectives, driving strategic planning, organizational transformation, and governance. His track record includes leading high-impact initiatives such as oncology-focused medical transitions, post-merger integrations, and clinical strategy reviews. Erik’s expertise in biotech and drug development strategy, coupled with his ability to optimize cross-functional collaboration, positions him to deliver transformative solutions in alignment with client goals and values

Key areas of expertise

• Biotech and drug development strategy 
• Medical and clinical operations optimization 
• Organizational transformation and governance 

Connect on LinkedIn

Hootan Khatami

SVP Medical

Hootan Khatami

SVP Medical

Dr. Hootan Khatami is a UCSF-trained endocrinologist and medical executive with nearly 25 years of combined academic and industry leadership in clinical and translational R&D, specializing in rare and metabolic disorders, incretin therapies and GLP1 metabolic products. He has directed programs from early discovery through global product launch, integrating medical strategy and execution. Experienced in orphan drug development, Advanced Therapies (including gene editing and gene therapy modalities), and corporate executive leadership as CEO and CMO, Dr. Khatami has successfully navigated complex clinical and regulatory pathways and led organizations in global launch readiness. His track record includes, managing multinational clinical programs, and forging strategic alliances that accelerate innovation and patient impact. 

Key areas of expertise

  • Early and late-stage drug development, translational metabolic research, and RWE studies 
  • TA’s including rare diseases (including orphan endocrine disorders); CV, lipidology and metabolic disorders; Endocrinology and Diabetes, and Incretin therapies, GLP-1 and associated mechanisms 
  • Global and US medical affairs and launch strategy and execution 
  • Corporate executive leadership, alliance management and Cross-functional leadership 
Connect on LinkedIn

Ramin Farhood

SVP Medical

Ramin Farhood

SVP Medical

Ramin Farhood is a senior medical executive with over two decades of global leadership in medical affairs, specializing in rare diseases and gene therapy. He has successfully built and scaled high-performing teams, directed strategic launches of transformative therapies, and aligned medical strategy with corporate goals. Known for his expertise in market access, HEOR, and RWE generation, Ramin has led cross-functional collaborations that secured reimbursement and accelerated innovation. His achievements include launching the first-ever gene therapy for SMA globally, managing substantial budgets, and establishing pioneering registries to support data-driven market readiness. 

Key areas of expertise

• Rare disease and gene therapy product launches 
• Health economics and real world evidence generation 
• Global medical affairs leadership and organizational development 

Connect on LinkedIn

Related Reading

Discover Our Podcast

Whether you're a seasoned executive or an aspiring leader, our podcast offers valuable perspectives and practical advice to support you at every stage of your product development journey. 

Listen Now

LET’S TALK

You don't have to go it alone!

Our experienced team has been there before, and we're ready to guide you through the unknown. Share your challenges with us, and together, we'll create a plan to efficiently reach your milestones and turn your vision into reality.

Building Better Biotechs